While GFAP helps maintain astrocyte structural integrity under normal conditions, its pathological overexpression contributes to depression-associated synaptic dysfunction, mainly through impaired neurotransmitter clearance (Sălcudean et al., 2025). The gene discussed is GFAP; the disease is depressive disorder.